As potential updates to Continuous Glucose Monitor (CGM) coverage continue to evolve, health plans must begin preparing now for what’s ahead.

In this on-demand webinar, CCS leaders Marian Lowe (Chief Strategy and Development Officer) and Coni Dennis (Chief Clinical Officer) explore what expanded access to CGM for members with Type 2 diabetes could mean—from day-one diagnosis to long-term population health outcomes.

Gain insights into emerging market and policy trends, key challenges facing health plans, and the critical role of engagement and support in delivering meaningful clinical value.